You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Prof. Dr. Olivia Merkel
Chair Holder and Deputy Director, Department of Pharmacy, LMU Faculty of Chemistry and Pharmacy
RNA therapeutics hold enormous potential for treating pulmonary diseases, but getting the right RNA into the right cells remains a major challenge. This talk will show how tuning nanoparticle structure and targeting can translate into functional gene silencing in the diseased lung and present new data pushing these systems toward preclinical therapeutic applications.
Dr. Benjamin Winkeljann
Co-founder and CEO of IZB-based start-up RNhale
While advances in nanomedicine are improving how RNA reaches target cells, successful pulmonary therapies also depend on how these medicines are delivered to the lung. This talk will explore the fundamentals of inhaled drug delivery, including aerosol generation, formulation design, particle engineering, and inhaler technologies, and present recent developments supporting the translation of RNA therapeutics into inhaled medicines.
Name (EN)
Function of Speakers
Topic:
Description of topic
Christian Gnam
Managing Director, IZB
Christian Gnam
Managing Director, IZB
Topic:
Description of topic
